CWM, LLC

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1535847 OMAHA, NE

Position in MLYS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$163,921

-$21,085 QoQ

Shares Held

6,051

+18.7% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Mar 31, 2026

CWM, LLC holds $167,669,597 across 306 Biotechnology names. MLYS ranks #72 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	66,400	$51,303,296
2	MRNA	Moderna, Inc.	386,906	$19,654,824
3	INCY	Incyte Corp	202,772	$19,084,900
4	EXEL	Exelixis, Inc.	263,476	$11,300,485
5	BMRN	Biomarin Pharmaceutical Inc	159,652	$9,018,741
6	ROIV	Roivant Sciences Ltd.	181,899	$5,038,602
7	SRPT	Sarepta Therapeutics, Inc.	198,333	$4,315,726
8	VRTX	Vertex Pharmaceuticals Inc / Ma	8,609	$3,844,262

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$163,921	6,051	+18.7%	Shares	Sole	2026-05-14
2025-12-31	$185,006	5,098	-8.9%	Shares	Sole	2026-01-26
2025-09-30	$212,238	5,597	-10.5%	Shares	Sole	2025-10-15
2025-06-30	$84,576	6,251	-25.1%	Shares	Sole	2025-07-25
2025-03-31	$132,470	8,342	+59.3%	Shares	Sole	2025-05-01
2024-12-31	$64,467	5,237	+0.3%	Shares	Sole	2025-02-04
2024-09-30	$63,250	5,223	-11.2%	Shares	Sole	2024-10-08
2024-06-30	$68,854	5,885	-0.1%	Shares	Sole	2024-07-10
2024-03-31	$76,052	5,891	0.0%	Shares	Sole	2024-04-05
2023-12-31	$50,662	5,891	+120.0%	Shares	Sole	2024-02-01
2023-09-30	$25,467	2,678	+20500.0%	Shares	Sole	2023-10-11
2023-03-31	$203	13	—	Shares	Sole	2023-05-01
No filing history on record for this holder in this stock.